Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
US-2019381199-A1 · Dec 19, 2019 · US
Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
US10857247B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10857247-B2 |
| Application number | US-201916555290-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 29, 2019 |
| Priority date | Mar 21, 2008 |
| Publication date | Dec 8, 2020 |
| Grant date | Dec 8, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
One aspect of the present invention relates to compounds, compositions and methods for diagnosis and/or treatment of a subject suffering from an amyloidosis-associated pathological condition. In certain embodiments, the imaging and/or therapeutic agents of the instant invention may be administered to a subject for identification and/or treatment of amyloid deposits. A specific imaging method detects amyloid deposits by administering the imaging agent to the subject and detecting the spatial distribution of the agent. Differential accumulation of the agent is indicative of AD or an amyloidosis-associated pathological condition and can be monitored by using a PET or SPECT camera.
First claim
Opening claim text (preview).
We claim: 1. A method for amyloid imaging a subject suffering from Alzheimer's disease comprising the step of: administering a diagnostically effective amount of to the subject.
Assignees
Inventors
Classifications
- A61K51/0497Primary
conjugates with a carrier being an organic compounds · CPC title
Isotopically modified compounds, e.g. labelled · CPC title
- C07C43/196Primary
containing hydroxy or O-metal groups · CPC title
The ring being saturated · CPC title
containing halogen · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10857247B2 cover?
- One aspect of the present invention relates to compounds, compositions and methods for diagnosis and/or treatment of a subject suffering from an amyloidosis-associated pathological condition. In certain embodiments, the imaging and/or therapeutic agents of the instant invention may be administered to a subject for identification and/or treatment of amyloid deposits. A specific imaging method de…
- Who is the assignee on this patent?
- Massachusetts Gen Hospital
- What technology area does this patent fall under?
- Primary CPC classification A61K51/0497. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).